CABAFLO Injection
Strength: 60mg/1.5ml
Description: Single use vial
Pack Size: 1 Vial
Storage Conditions: Stored at 25°C (77°F).
Approved Indications of CABAFLO
- Metastatic Castration-Resistant Prostate Cancer (mCRPC): Cabazitaxel is indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in patients who have previously received docetaxel, another chemotherapy drug.
